e.g. Tata motors, Reliance MF, 500570

Aurobindo Pharma Ltd. - Research Center

524804 AUROPHARMA Group (A) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 10,933.30 10,645.64 12,792.28 11,287.14 15,823.68
Expenses
Material consumed 5,680.64 5,917.42 7,009.99 5,981.37 7,425.56
Manufacturing expenses 185.59 191.58 613.92 477.99 512.34
Personnel expenses 1,063.07 980.56 1,641.88 1,600.04 1,735.42
Selling expenses - - - - -
Adminstrative expenses 1,446.43 1,332.04 1,795.57 1,754.34 2,030.53
Expenses capitalised - - - - -
Cost of sales 8,375.73 8,421.60 11,061.36 9,813.74 11,703.85
Operating profit 2,557.57 2,224.04 1,730.92 1,473.40 4,119.83
Other recurring income 328.12 616.06 433.76 670.99 589.86
Adjusted PBDIT 2,885.69 2,840.10 2,164.68 2,144.39 4,709.69
Financial expenses 230.04 182.60 114.98 16.94 28.68
Depreciation 297.20 254.58 435.35 415.26 488.00
Other write offs - - - - -
Adjusted PBT 2,358.45 2,402.92 1,614.35 1,712.19 4,193.01
Tax charges 611.66 502.82 383.94 182.77 1,080.10
Adjusted PAT 1,746.79 1,900.10 1,230.41 1,529.42 3,112.91
Non recurring items -5.26 52.35 5.87 -73.02 -6.42
Other non cash adjustments - - - - -
Reported net profit 1,741.53 1,952.45 1,236.28 1,456.40 3,106.49
Earnigs before appropriation 20,090.40 18,612.53 17,100.42 16,127.81 14,905.79
Equity dividend - 263.66 439.45 263.67 234.38
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 20,090.40 18,348.87 16,660.97 15,864.14 14,671.41
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback